• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术后肝性脑病的治疗:肠道微生物群的新视角

Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota.

作者信息

Xu Xiaotong, Zhu Tong, Jing Changyou, Jiang Minjie, Fu Yunlai, Xie Fang, Meng Qinghua, Li Jianjun

机构信息

Department of Oncology, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.

出版信息

Front Med (Lausanne). 2025 Mar 7;12:1423780. doi: 10.3389/fmed.2025.1423780. eCollection 2025.

DOI:10.3389/fmed.2025.1423780
PMID:40124683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11926149/
Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) placement alleviates portal hypertension symptoms. Hepatic encephalopathy (HE) is a common complication of TIPS, impacting patient quality of life and the healthcare burden. Post-TIPS HE is associated with portosystemic shunting, elevated blood ammonia levels, and inflammation. Increasing attention has been given to the liver and intestinal circulation in recent years. An imbalance in intestinal microecology plays a role in the occurrence of HE and may be a new target for treatment. This review discusses the causes, diagnosis, and treatment strategies for post-TIPS HE and focuses on exploring treatment strategies and their relationships with the gut microbiota, suggesting an innovative approach to address this complication.

摘要

经颈静脉肝内门体分流术(TIPS)置放可缓解门静脉高压症状。肝性脑病(HE)是TIPS的常见并发症,影响患者生活质量及医疗负担。TIPS术后HE与门体分流、血氨水平升高及炎症相关。近年来,肝脏和肠道循环越来越受到关注。肠道微生态失衡在HE的发生中起作用,可能成为新的治疗靶点。本文综述了TIPS术后HE的病因、诊断及治疗策略,重点探讨治疗策略及其与肠道微生物群的关系,提出应对这一并发症的创新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1bc/11926149/657a3d8ae076/fmed-12-1423780-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1bc/11926149/714661e3fdde/fmed-12-1423780-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1bc/11926149/657a3d8ae076/fmed-12-1423780-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1bc/11926149/714661e3fdde/fmed-12-1423780-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1bc/11926149/657a3d8ae076/fmed-12-1423780-g002.jpg

相似文献

1
Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota.经颈静脉肝内门体分流术后肝性脑病的治疗:肠道微生物群的新视角
Front Med (Lausanne). 2025 Mar 7;12:1423780. doi: 10.3389/fmed.2025.1423780. eCollection 2025.
2
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.肠道微生物群的恢复与经颈静脉肝内门体分流术后肝性脑病风险降低相关。
JHEP Rep. 2022 Feb 15;4(5):100448. doi: 10.1016/j.jhepr.2022.100448. eCollection 2022 May.
3
Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications.经颈静脉肝内门体分流术后乙肝相关性门静脉高压症患者肠道微生物群的变化:机制及临床意义
World J Gastroenterol. 2025 Jan 21;31(3):100752. doi: 10.3748/wjg.v31.i3.100752.
4
Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension.经颈静脉肝内门体分流术治疗乙型肝炎相关门静脉高压症患者的肠道微生物组改变。
World J Gastroenterol. 2024 Aug 21;30(31):3668-3679. doi: 10.3748/wjg.v30.i31.3668.
5
Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions.经颈静脉肝内门体分流术后肝性脑病的管理:当前策略与未来方向。
World J Gastroenterol. 2025 Apr 21;31(15):103512. doi: 10.3748/wjg.v31.i15.103512.
6
6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding.6毫米分流的经颈静脉肝内门体分流术用于治疗严重肝萎缩和静脉曲张出血患者。
Eur Radiol. 2024 Jul;34(7):4697-4707. doi: 10.1007/s00330-023-10346-3. Epub 2023 Nov 25.
7
Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement.种族和梯度差异与经颈静脉肝内门体分流术(TIPS)后肝性脑病住院风险增加相关。
J Clin Exp Hepatol. 2018 Sep;8(3):256-261. doi: 10.1016/j.jceh.2017.12.003. Epub 2017 Dec 30.
8
Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.经颈静脉肝内门体分流术难治性肝性脑病的当前诊断与管理
Liver Int. 2015 Dec;35(12):2487-94. doi: 10.1111/liv.12956. Epub 2015 Sep 28.
9
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.经颈静脉肝内门体分流术时经皮穿刺左支门静脉以减少肝性脑病。
World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. doi: 10.3748/wjg.v25.i9.1088.
10
The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.自发性门体分流的存在会增加经颈静脉肝内门体分流术(TIPS)置入术后并发症的风险。
Diagn Interv Imaging. 2016 Jun;97(6):643-50. doi: 10.1016/j.diii.2016.02.004. Epub 2016 Mar 2.

本文引用的文献

1
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial.微生物群移植治疗肝硬化肝性脑病:THEMATIC试验。
J Hepatol. 2025 Jan 10. doi: 10.1016/j.jhep.2024.12.047.
2
Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension.经颈静脉肝内门体分流术治疗乙型肝炎相关门静脉高压症患者的肠道微生物组改变。
World J Gastroenterol. 2024 Aug 21;30(31):3668-3679. doi: 10.3748/wjg.v30.i31.3668.
3
Gut-Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers.
门脉高压症中肠道-肝脏轴失调:新兴前沿。
Nutrients. 2024 Apr 1;16(7):1025. doi: 10.3390/nu16071025.
4
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001-2023).肝硬化中肠道微生物群的研究综述与展望:一项文献计量分析(2001 - 2023年)
Front Microbiol. 2024 Mar 14;15:1342356. doi: 10.3389/fmicb.2024.1342356. eCollection 2024.
5
Nontraditional Treatment of Hepatic Encephalopathy.非传统治疗肝性脑病。
Clin Liver Dis. 2024 May;28(2):297-315. doi: 10.1016/j.cld.2024.01.007. Epub 2024 Feb 15.
6
Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease.慢性肝病患者预后相关微生物群的鉴定
Microorganisms. 2024 Mar 19;12(3):610. doi: 10.3390/microorganisms12030610.
7
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.经颈静脉肝内门体分流术后发作性显性肝性脑病不会增加肝硬化患者的死亡率。
J Hepatol. 2024 Apr;80(4):596-602. doi: 10.1016/j.jhep.2023.11.033. Epub 2023 Dec 13.
8
Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.肝硬化患者肌少症的患病率及相关因素:系统评价和荟萃分析。
Clin Nutr. 2024 Jan;43(1):84-94. doi: 10.1016/j.clnu.2023.11.008. Epub 2023 Nov 14.
9
Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术围手术期肝性脑病的防治
World J Gastrointest Surg. 2023 Aug 27;15(8):1564-1573. doi: 10.4240/wjgs.v15.i8.1564.
10
Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry.通过质谱分析发现,门体分流术的放置揭示了肝性脑病发展的血液特征。
Nat Commun. 2023 Aug 31;14(1):5303. doi: 10.1038/s41467-023-40741-9.